

NCT00324363 Processed comparison:

Summary:
CHIA has 8 criteria while your personal folder has 13 criteria
Total found criteria: 7/8
Total not Found: 1/8
Total Extra: 5
This trial is INVALID



╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╕
│ CHIA Criteria                                      │ Matching Personal Criteria                         │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╡
│ HbA1c between 7 1% and 11 0% inclusive             │ HbA1c between 7 1% and 11 0% inclusive             │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Body Mass Index (BMI) >21 kg/m^2 and <35 kg/m^2    │ Body Mass Index (BMI) >21 kg/m^2 and <35 kg/m^2    │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Have participated in this study previously or any  │ Have participated in this study previously or any  │
│ other study using exenatide or GLP-1 analogs       │ other study using exenatide or GLP-1 analogs       │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Have participated in an interventional medical     │ Have participated in an interventional medical     │
│ surgical or pharmaceutical study within 30 days of │ surgical or pharmaceutical study within 30 days of │
│ screening                                          │ screening                                          │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Have characteristics contraindicating metformin or │ Have characteristics contraindicating metformin or │
│ sulfonylurea use                                   │ sulfonylurea use                                   │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Have been treated with exogenous insulin for more  │ Have been treated with exogenous insulin for more  │
│ than 1 week within the 3 months prior to screening │ than 1 week within the 3 months prior to screening │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Have used drugs for weight loss within 1 month of  │ Have used drugs for weight loss within 1 month of  │
│ screening                                          │ screening                                          │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╛



╒══════════════════════════════════════════════════════════════════════════════════════════════════════╕
│ CHIA Criteria Not Found in Personal                                                                  │
╞══════════════════════════════════════════════════════════════════════════════════════════════════════╡
│ Treated with a stable dose of one of the following for at least 3 months prior to screening * >=1000 │
│ mg/day immediate-release metformin or metformin >=1000 mg/day and sulfonylurea or                    │
│ sulfonylurea/metformin combination therapy                                                           │
╘══════════════════════════════════════════════════════════════════════════════════════════════════════╛



╒════════════════════════════════════════════════════════════════════════════════════════════════════╕
│ Extra Personal Criteria                                                                            │
╞════════════════════════════════════════════════════════════════════════════════════════════════════╡
│ Treated with a stable dose of one of the following for at least 3 months prior to screening >=1000 │
│ mg/day immediate-release metformin                                                                 │
├────────────────────────────────────────────────────────────────────────────────────────────────────┤
│ Must have maximum age of 75 Years                                                                  │
├────────────────────────────────────────────────────────────────────────────────────────────────────┤
│ Must have minimum age of 21 Years                                                                  │
├────────────────────────────────────────────────────────────────────────────────────────────────────┤
│ Treated with a stable dose of one of the following for at least 3 months prior to screening        │
│ metformin >=1000 mg/day and sulfonylurea                                                           │
├────────────────────────────────────────────────────────────────────────────────────────────────────┤
│ Treated with a stable dose of one of the following for at least 3 months prior to screening        │
│ sulfonylurea/metformin combination therapy                                                         │
╘════════════════════════════════════════════════════════════════════════════════════════════════════╛